R. Vassell

发表

Cross-Neutralizing Antibodies to Pandemic 2009 H1N1 and Recent Seasonal H1N1 Influenza A Strains Influenced by a Mutation in Hemagglutinin Subunit 2

Dorothy Scott, Min Zhuang, Hong Yang, 2011, PLoS pathogens.

A mutation in the receptor binding site enhances infectivity of 2009 H1N1 influenza hemagglutinin pseudotypes without changing antigenicity.

J. Castelán-Vega, Alicia Jiménez-Alberto, Wei Wang, 2010, Virology.

Characterization of lentiviral pseudotypes with influenza H5N1 hemagglutinin and their performance in neutralization assays.

Hang Xie, Wei Wang, R. Vassell, 2010, Journal of virological methods.

stablishment of retroviral pseudotypes with influenza hemagglutinins rom H 1 , H 3 , and H 5 subtypes for sensitive and specific detection of eutralizing antibodies

R. Vassell, ei Wanga, Eboneé N. Butlerb, 2008 .

Establishment of retroviral pseudotypes with influenza hemagglutinins from H1, H3, and H5 subtypes for sensitive and specific detection of neutralizing antibodies.

Wei Wang, R. Vassell, Z. Ye, 2008, Journal of virological methods.

HIV-1 gp41 Residues Modulate CD4-Induced Conformational Changes in the Envelope Glycoprotein and Evolution of a Relaxed Conformation of gp120

R. Vassell, C. Weiss, P. Keller, 2018, Journal of Virology.

Trimeric, Coiled-coil Extension on Peptide Fusion Inhibitor of HIV-1 Influences Selection of Resistance Pathways*

Wei Wang, Christopher J. De Feo, M. Zhuang, 2012, The Journal of Biological Chemistry.

Transcutaneous Immunization with Bacterial ADP-Ribosylating Exotoxins as Antigens and Adjuvants

G. Matyas, C. Alving, G. Glenn, 1999, Infection and Immunity.

Selection with a Peptide Fusion Inhibitor Corresponding to the First Heptad Repeat of HIV-1 gp41 Identifies Two Genetic Pathways Conferring Cross-Resistance to Peptide Fusion Inhibitors Corresponding to the First and Second Heptad Repeats (HR1 and HR2) of gp41

Wei Wang, Christopher J. De Feo, M. Zhuang, 2011, Journal of Virology.

Generation of a protective murine monoclonal antibody against the stem of influenza hemagglutinins from group 1 viruses and identification of resistance mutations against it

Esmeralda Alvarado-Facundo, Wei Wang, R. Vassell, 2019, PloS one.

Glycosylation of Residue 141 of Subtype H7 Influenza A Hemagglutinin (HA) Affects HA-Pseudovirus Infectivity and Sensitivity to Site A Neutralizing Antibodies

Esmeralda Alvarado-Facundo, Wei Wang, R. Vassell, 2016, PloS one.

Neutralizing Antibody Responses to Homologous and Heterologous H1 and H3 Influenza A Strains After Vaccination With Inactivated Trivalent Influenza Vaccine Vary With Age and Prior-year Vaccination.

L. Katzelnick, Wei Wang, R. Vassell, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Serum Samples From Middle-aged Adults Vaccinated Annually with Seasonal Influenza Vaccines Cross-neutralize Some Potential Pandemic Influenza Viruses

D. Scott, Esmeralda Alvarado-Facundo, Wei Wang, 2015, The Journal of infectious diseases.

Peptides Corresponding to the Heptad Repeat Motifs in the Transmembrane Protein (gp41) of Human Immunodeficiency Virus Type 1 Elicit Antibodies to Receptor-Activated Conformations of the Envelope Glycoprotein

P. Wingfield, R. Vassell, C. Weiss, 2001, Journal of Virology.

Characterization of Entry Pathways, Species-Specific Angiotensin-Converting Enzyme 2 Residues Determining Entry, and Antibody Neutralization Evasion of Omicron BA.1, BA.1.1, BA.2, and BA.3 Variants

Wei Wang, R. Vassell, C. Weiss, 2022, Journal of virology.

Characterization of entry pathways, species-specific ACE2 residues determining entry, and antibody neutralization evasion of Omicron BA.1, BA.1.1, BA.2, and BA.3 variants

Wei Wang, R. Vassell, C. Weiss, 2022, bioRxiv.

SARS-CoV-2 antibodies remain detectable 12 months after infection and antibody magnitude is associated with age and COVID-19 severity

C. Broder, R. Vassell, C. Weiss, 2021, medRxiv.

Durability of antibody responses and frequency of clinical and subclinical SARS-CoV-2 infection six months after BNT162b2 COVID-19 vaccination in healthcare workers

W. Wang, C. Broder, R. Vassell, 2021, medRxiv.

Resistance to N-peptide fusion inhibitors correlates with thermodynamic stability of the gp41 six-helix bundle but not HIV entry kinetics

Wei Wang, Christopher J. De Feo, M. Zhuang, 2014, Retrovirology.

Post-vaccination Omicron infections induce broader immunity across antigenic space than prototype mRNA COVID-19 booster vaccination or primary infection

Rupal M Mody, C. Broder, B. Agan, 2022, bioRxiv.

The trispecific DARPin ensovibep inhibits diverse SARS-CoV-2 variants

A. Gruber, B. Bosch, H. Binz, 2022, Nature biotechnology.

Recombinant A27 protein synergizes with modified vaccinia Ankara in conferring protection against a lethal vaccinia virus challenge.

R. Vassell, C. Weiss, M. Merchlinsky, 2010, Vaccine.

SARS-CoV-2 Omicron neutralization by therapeutic antibodies, convalescent sera, and post-mRNA vaccine booster

Rupal M Mody, C. Broder, B. Agan, 2021, bioRxiv.

Pathogenesis of hepatitis A in orally inoculated owl monkeys (Aotus trivirgatus)

R. Vassell, L. Asher, L. Binn, 1995, Journal of medical virology.

Antibodies to the A27 protein of vaccinia virus neutralize and protect against infection but represent a minor component of Dryvax vaccine--induced immunity.

I. Berkower, J. Manischewitz, H. Golding, 2007, The Journal of infectious diseases.

Lethal Mucosal Toxin Challenge with Cholera Toxin Protects Mice Against Cutting Edge: Transcutaneous Immunization

C. Alving, G. Glenn, R. Vassell, 1998 .

Antigenic cartography of well-characterized human sera shows SARS-CoV-2 neutralization differences based on infection and vaccination history

C. Broder, B. Agan, L. Katzelnick, 2022, Cell Host & Microbe.

Resistance to N-peptide fusion inhibitors correlates with thermodynamic stability of the gp41 six-helix bundle but not HIV entry kinetics

Wei Wang, Christopher J. De Feo, M. Zhuang, 2014, Retrovirology.

Key Substitutions in the Spike Protein of SARS-CoV-2 Variants Can Predict Resistance to Monoclonal Antibodies, but Other Substitutions Can Modify the Effects

A. Eakin, Wei Wang, R. Vassell, 2021, bioRxiv.

D-dimer and CoV-2 spike-immune complexes contribute to the production of PGE2 and proinflammatory cytokines in monocytes

Yun-Jong Park, S. Khurana, H. Golding, 2022, PLoS pathogens.

Immunohistochemical Detection of Cytokines in Tissues of Aotus Monkeys Infected with Hepatitis A Virus

R. Vassell, L. Asher, L. Binn, 1994, Annals of the New York Academy of Sciences.

Transcutaneous immunization with cholera toxin protects mice against lethal mucosal toxin challenge.

C. Alving, G. Glenn, R. Vassell, 1998, Journal of immunology.

Multispecific DARPin® therapeutics demonstrate very high potency against SARS-CoV-2 variants in vitro

M. Stumpp, A. Bosshart, F. Malvezzi, 2021 .

Human Immunodeficiency Virus (HIV) gp41 Escape Mutants: Cross-Resistance to Peptide Inhibitors of HIV Fusion and Altered Receptor Activation of gp120

Yong He, Paul Wingfield, P. Wingfield, 2005, Journal of Virology.

Peptides Trap the Human Immunodeficiency Virus Type 1 Envelope Glycoprotein Fusion Intermediate at Two Sites

Nga Nguyen, Yong He, R. Vassell, 2003, Journal of Virology.

Transcutaneous Immunization with Bacterial ADP-Ribosylating Exotoxins, Subunits, and Unrelated Adjuvants

C. Alving, G. Glenn, R. Vassell, 2000, Infection and Immunity.

Bivalent COVID-19 vaccine antibody responses to Omicron variants suggest that responses to divergent variants would be improved with matched vaccine antigens

Wei Wang, R. Vassell, C. Weiss, 2023, medRxiv.

Establishment of a well-characterized SARS-CoV-2 lentiviral pseudovirus neutralization assay using 293T cells with stable expression of ACE2 and TMPRSS2

Wei Wang, R. Vassell, C. Weiss, 2020, bioRxiv.

SARS-CoV-2 Delta Variant Displays Moderate Resistance to Neutralizing Antibodies and Spike Protein Properties of Higher Soluble ACE2 Sensitivity, Enhanced Cleavage and Fusogenic Activity

L. Katzelnick, A. Eakin, Wei Wang, 2021, Viruses.

SARS-COV-2 Delta variant displays moderate resistance to neutralizing antibodies and spike protein properties of higher soluble ACE2 sensitivity, enhanced cleavage and fusogenic activity

L. Katzelnick, A. Eakin, Wei Wang, 2021, bioRxiv.

Principles of transcutaneous immunization using cholera toxin as an adjuvant.

C. Alving, G. Glenn, R. Vassell, 1999, Vaccine.

SARS-CoV-2 BA.1 variant is neutralized by vaccine booster-elicited serum, but evades most convalescent serum and therapeutic antibodies

C. Broder, B. Agan, L. Katzelnick, 2022, Science Translational Medicine.

Durability of Antibody Response and Frequency of SARS-CoV-2 Infection 6 Months after COVID-19 Vaccination in Healthcare Workers

C. Broder, R. Vassell, C. Weiss, 2022, Emerging infectious diseases.

Neutralizing Antibodies Targeting the Conserved Stem Region of Influenza Hemagglutinin

R. Vassell, C. Weiss, Sabari Nath Neerukonda, 2020, Vaccines.

Conformational Stability of the Hemagglutinin of H5N1 Influenza A Viruses Influences Susceptibility to Broadly Neutralizing Stem Antibodies

Esmeralda Alvarado-Facundo, Wei Wang, R. Vassell, 2018, Journal of Virology.

Intermonomer Interactions in Hemagglutinin Subunits HA1 and HA2 Affecting Hemagglutinin Stability and Influenza Virus Infectivity

Esmeralda Alvarado-Facundo, Wei Wang, R. Vassell, 2015, Journal of Virology.

Live rubella vectors can express native HIV envelope glycoproteins targeted by broadly neutralizing antibodies and prime the immune response to an envelope protein boost.

L. Stamatatos, A. McGuire, I. Berkower, 2018, Vaccine.

Comparison of A(H3N2) neutralizing antibody responses elicited by 2018-2019 season quadrivalent influenza vaccines derived from eggs, cells, and recombinant hemagglutinin.

M. Eichelberger, A. Ganesan, Esmeralda Alvarado-Facundo, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Immunogens Modeling a Fusion-Intermediate Conformation of gp41 Elicit Antibodies to the Membrane Proximal External Region of the HIV Envelope Glycoprotein

D. Montefiori, C. Labranche, I. Srivastava, 2015, PloS one.

Binding of the 2F5 Monoclonal Antibody to Native and Fusion-Intermediate Forms of Human Immunodeficiency Virus Type 1 gp41: Implications for Fusion-Inducing Conformational Changes

Shibo Jiang, R. Kunert, R. Vassell, 2004, Journal of Virology.

D614G and Omicron SARS-CoV-2 variant spike proteins differ in the effects of N-glycan modifications on spike expression, virus infectivity, and neutralization by some therapeutic antibodies

Wei Wang, R. Vassell, C. Weiss, 2023, bioRxiv.

Effects of N-glycan modifications on spike expression, virus infectivity, and neutralization sensitivity in ancestral compared to Omicron SARS-CoV-2 variants

Wei Wang, R. Vassell, C. Weiss, 2023, PLoS pathogens.